Abstract
Background: Current clinical practice is to evaluate children presenting with premature adrenarche (PA) for non-classical congenital adrenal hyperplasia (NC-CAH). Our main objective was to assess the prevalence of NC-CAH among children presented with PA. Additional objectives were to ascertain whether subpopulations were prone to NC-CAH, and therefore justified to be tested, and if obesity is a factor that can exclude the need for CAH testing.
Methods: A retrospective chart review of all children ≤11 years, who presented to our clinic with PA between January 2012 and May 2015 (n=103) was conducted. PA was defined based on commonly accepted clinical criteria.
Results: We did not identify any subjects with NC-CAH but one was affected with previously undiagnosed classical simple virilizing CAH (SV-CAH). The subject was born prior to the implementation of CAH newborn screening in the state of birth. The affected subject was of Middle Eastern origin and also obese (BMI >95 percentile for age and sex).
Conclusions: Undiagnosed CAH is an uncommon cause of PA, and therefore routine screening for NC-CAH in every case of PA may not be justified, although, perhaps, should still be considered in high risk ethnicities. Obesity does not appear to exclude the possibility of being affected with mild or NC-CAH.
References
1. Williams RM, Ward CE, Hughes IA. Premature adrenarche. Arch Dis Child 2012;97:250–4.10.1136/archdischild-2011-300011Search in Google Scholar PubMed
2. Idkowiak J, Lavery GG, Dhir V, Barrett TG, Stewart PM, et al. Premature adrenarche: novel lessons from early onset androgen excess. Eur J Endocrinol 2011;165:189–207.10.1530/EJE-11-0223Search in Google Scholar PubMed
3. Utriainen P, Laakso S, Liimatta J, Jaaskelainen J, Voutilainen R. Premature adrenarche – a common condition with variable presentation. Horm Res Paediatr 2015;83:221–31.10.1159/000369458Search in Google Scholar PubMed
4. Belgorosky A, Baquedano MS, Guercio G, Rivarola MA. Adrenarche: postnatal adrenal zonation and hormonal and metabolic regulation. Horm Res 2008;70:257–67.10.1159/000157871Search in Google Scholar PubMed
5. Rege J, Rainey WE. The steroid metabolome of adrenarche. J Endocrinol 2012;214:133–43.10.1530/JOE-12-0183Search in Google Scholar PubMed PubMed Central
6. Ibanez L, Virdis R, Potau N, Zampolli M, Ghizzoni L, et al. Natural history of premature pubarche: an auxological study. J Clin Endocrinol Metab 1992;74:254–7.10.1210/jc.74.2.254Search in Google Scholar
7. Vottero A, Capelletti M, Giuliodori S, Viani I, Ziveri M, et al. Decreased androgen receptor gene methylation in premature pubarche: a novel pathogenetic mechanism? J Clin Endocrinol Metab 2006;91:968–72.10.1210/jc.2005-2354Search in Google Scholar PubMed
8. Berberoglu M. Precocious puberty and normal variant puberty: definition, etiology, diagnosis and current management. J Clin Res Pediatr Endocrinol 2009;1:164–74.10.4274/jcrpe.v1i4.3Search in Google Scholar PubMed PubMed Central
9. Counts DR, Pescovitz OH, Barnes KM, Hench KD, Chrousos GP, et al. Dissociation of adrenarche and gonadarche in precocious puberty and in isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1987;64:1174–8.10.1210/jcem-64-6-1174Search in Google Scholar PubMed
10. Ghizzoni L, Mastorakos G, Vottero A. Adrenal hyperandrogenism in children. J Clin Endocrinol Metab 1999;84:4431–5.10.1210/jcem.84.12.6284Search in Google Scholar PubMed
11. Denburg MR, Silfen ME, Manibo AM, Chin D, Levine LS, et al. Insulin sensitivity and the insulin-like growth factor system in prepubertal boys with premature adrenarche. J Clin Endocrinol Metab 2002;87:5604–9.10.1210/jc.2002-020896Search in Google Scholar PubMed
12. Vuguin P, Grinstein G, Freeman K, Saenger P, DiMartino Nardi J. Prediction models for insulin resistance in girls with premature adrenarche. The premature adrenarche insulin resistance score: PAIR score. Horm Res 2006;65:185–91.Search in Google Scholar
13. Siegel SF, Finegold DN, Urban MD, McVie R, Lee PA. Premature pubarche: etiological heterogeneity. J Clin Endocrinol Metab 1992;74:239–47.Search in Google Scholar
14. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. J Am Med Assoc 2012;307:483–90.10.1001/jama.2012.40Search in Google Scholar PubMed PubMed Central
15. Oppenheimer E, Linder B, DiMartino-Nardi J. Decreased insulin sensitivity in prepubertal girls with premature adrenarche and acanthosis nigricans. J Clin Endocrinol Metab 1995;80:614–8.Search in Google Scholar
16. Mathew RP, Byrne DW, Linton MF, Vaughan DE, Fazio S, et al. Evidence of metabolic syndrome in lean children with premature pubarche at diagnosis. Metabolism 2008;57:733–40.10.1016/j.metabol.2008.01.010Search in Google Scholar PubMed
17. Utriainen P, Jaaskelainen J, Romppanen J, Voutilainen R. Childhood metabolic syndrome and its components in premature adrenarche. J Clin Endocrinol Metab 2007;92:4282–5.10.1210/jc.2006-2412Search in Google Scholar PubMed
18. DiMartino-Nardi J. Pre- and postpuberal findings in premature adrenarche. J Pediatr Endocrinol Metab 2000;13(Suppl 5):1265–9.Search in Google Scholar
19. New MI. An update of congenital adrenal hyperplasia. Ann NY Acad Sci 2004;1038:14–43.10.1196/annals.1315.009Search in Google Scholar PubMed
20. New MI. Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 2006;91:4205–14.10.1210/jc.2006-1645Search in Google Scholar PubMed
21. Kohn B, Levine LS, Pollack MS, Pang S, Lorenzen F, et al. Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 1982;55:817–27.10.1210/jcem-55-5-817Search in Google Scholar PubMed
22. Leite MV, Mendonca BB, Arnhold IJ, Estefan V, Nunes C, et al. Identification of nonclassical 21-hydroxylase deficiency in girls with precocious pubarche. J Endocrinol Invest 1991;14:11–5.10.1007/BF03350247Search in Google Scholar PubMed
23. Armengaud JB, Charkaluk ML, Trivin C, Tardy V, Breart G, et al. Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche. J Clin Endocrinol Metab 2009;94:2835–40.10.1210/jc.2009-0314Search in Google Scholar PubMed
24. New MI. Genetic disorders of adrenal hormone synthesis. Horm Res 1992;37(Suppl 3):22–33.10.1159/000182397Search in Google Scholar PubMed
25. Migeon CJ, Donohoue PA. Congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. Its molecular basis and its remaining therapeutic problems. Endocrinol Metab Clin North Am 1991;20:277–96.10.1016/S0889-8529(18)30269-XSearch in Google Scholar
26. New MI, Abraham M, Gonzalez B, Dumic M, Razzaghy-Azar M, et al. Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci USA 2013;110:2611–6.10.1073/pnas.1300057110Search in Google Scholar PubMed PubMed Central
27. Cutler GB, Jr., Laue L. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 1990;323:1806–13.10.1056/NEJM199012273232605Search in Google Scholar PubMed
28. Witchel SF, Azziz R. Nonclassic congenital adrenal hyperplasia. Int J Pediatr Endocrinol 2010;2010:625105.10.1186/1687-9856-2010-625105Search in Google Scholar
29. Binay C, Simsek E, Cilingir O, Yuksel Z, Kutlay O, et al. Prevalence of nonclassic congenital adrenal hyperplasia in Turkish children presenting with premature pubarche, hirsutism, or oligomenorrhoea. Int J Endocrinol 2014;2014:768506.10.1155/2014/768506Search in Google Scholar PubMed PubMed Central
30. Temeck JW, Pang SY, Nelson C, New MI. Genetic defects of steroidogenesis in premature pubarche. J Clin Endocrinol Metab 1987;64:609–17.10.1210/jcem-64-3-609Search in Google Scholar PubMed
31. Sathasivam A, Garibaldi L, Shapiro S, Godbold J, Rapaport R. Leuprolide stimulation testing for the evaluation of early female sexual maturation. Clin Endocrinol 2010;73:375–81.10.1111/j.1365-2265.2010.03796.xSearch in Google Scholar PubMed
32. Carel JC, Lahlou N, Roger M, Chaussain JL. Precocious puberty and statural growth. Hum Reprod Update 2004;10:135–47.10.1093/humupd/dmh012Search in Google Scholar PubMed
33. Gonc EN, Ozon ZA, Alikasifoglu A, Engiz O, Bulum B, Kandemir N. Is basal serum 17-OH progesterone a reliable parameter to predict nonclassical congenital adrenal hyperplasia in premature adrenarche? Turk J Pediatr 2011;53:274–80.Search in Google Scholar
34. Ghizzoni L, Cappa M, Vottero A, Ubertini G, Carta D, et al. Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche. Eur J Endocrinol 2011;165:307–14.10.1530/EJE-11-0119Search in Google Scholar PubMed
35. Hassiakos DK, Toner JP, Jones GS, Jones HW, Jr. Late-onset congenital adrenal hyperplasia in a group of hyperandrogenic women. Arch Gynecol Obstet 1991;249:165–71.10.1007/BF02390383Search in Google Scholar PubMed
36. Krone N, Riepe FG, Partsch CJ, Vorhoff W, Bramswig J, et al. Three novel point mutations of the CYP21 gene detected in classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Exp Clin Endocrinol Diabetes 2006;114:111–7.10.1055/s-2005-872841Search in Google Scholar PubMed
37. Loidi L, Quinteiro C, Parajes S, Barreiro J, Leston DG, et al. High variability in CYP21A2 mutated alleles in Spanish 21-hydroxylase deficiency patients, six novel mutations and a founder effect. Clin Endocrinol 2006;64:330–6.10.1111/j.1365-2265.2006.02465.xSearch in Google Scholar PubMed
38. Haider S, Islam B, D’Atri V, Sgobba M, Poojari C, et al. Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia. Proc Natl Acad Sci USA 2013;110:2605–10.10.1073/pnas.1221133110Search in Google Scholar PubMed PubMed Central
39. Phedonos AA, Shammas C, Skordis N, Kyriakides TC, Neocleous V, et al. High carrier frequency of 21-hydroxylase deficiency in Cyprus. Clin Genet 2013;84:585–8.10.1111/cge.12153Search in Google Scholar PubMed
40. Pang SY, Wallace MA, Hofman L, Thuline HC, Dorche C, et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988;81:866–74.Search in Google Scholar
41. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. J Am Med Assoc 2014;311:806–14.10.1001/jama.2014.732Search in Google Scholar PubMed PubMed Central
42. Trapp CM, Speiser PW, Oberfield SE. Congenital adrenal hyperplasia: an update in children. Curr Opin Endocrinol Diabetes Obes 2011;18:166–70.10.1097/MED.0b013e328346938cSearch in Google Scholar PubMed PubMed Central
©2016 by De Gruyter
